Ramosetron, Aprepitant and Dexamethasone (RAD) in Solid Cancer
NCT01046461
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
41
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumour
Postoperative Nausea and Vomiting
Interventions
DRUG:
Ramosetron, Aprepitant, Dexamethasone
Sponsor
Hallym University Medical Center
Collaborators
[object Object]